BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND NTRK1, ENSG00000198400, 4914, P04629, TRK1, MTC, DKFZp781I14186, p140-TrkA, TRKA, TRK AND Diagnosis
44 results:

  • 1. Oncocytoid Salivary Tumors: Differential diagnosis and Utility of Newly Described Immunohistochemistry.
    Katabi N
    Head Neck Pathol; 2024 Mar; 18(1):20. PubMed ID: 38502259
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Whole-Genome Sequencing Analysis of Male breast cancer Unveils Novel Structural Events and Potential Therapeutic Targets.
    Al Assaad M; Michaud O; Semaan A; Sigouros M; Tranquille M; Phan A; Levine MF; Gundem G; Medina-Martínez JS; Papaemmanuil E; Manohar J; Wilkes D; Sboner A; Hoda SAF; Elemento O; Mosquera JM
    Mod Pathol; 2024 Apr; 37(4):100452. PubMed ID: 38369186
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Expression and Signaling Pathways of Nerve Growth Factor (NGF) and Pro-NGF in breast cancer: A Systematic Review.
    Bruno F; Arcuri D; Vozzo F; Malvaso A; Montesanto A; Maletta R
    Curr Oncol; 2022 Oct; 29(11):8103-8120. PubMed ID: 36354700
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Secretory carcinoma of the sinonasal cavity and pharynx: A retrospective analysis of four cases and literature review.
    Yue C; Zhao X; Ma D; Piao Y
    Ann Diagn Pathol; 2022 Dec; 61():152052. PubMed ID: 36270241
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Expert consensus on the diagnosis and treatment of Ntrk gene fusion solid tumors in China.
    Xu C; Si L; Wang W; Li Z; Song Z; Wang Q; Liu A; Yu J; Fang W; Zhong W; Wang Z; Zhang Y; Liu J; Zhang S; Cai X; Liu A; Li W; Zhan P; Liu H; Lv T; Miao L; Min L; Chen Y; Yuan J; Wang F; Jiang Z; Lin G; Pu X; Lin R; Liu W; Rao C; Lv D; Yu Z; Lei L; Li X; Tang C; Zhou C; Zhang J; Xue J; Guo H; Chu Q; Meng R; Wu J; Zhang R; Hu X; Zhou J; Zhu Z; Li Y; Qiu H; Xia F; Lu Y; Chen X; Ge R; Dai E; Han Y; Pan W; Luo J; Jia H; Dong X; Pang F; Wang K; Wang L; Zhu Y; Xie Y; Lin X; Cai J; Wei J; Lan F; Feng H; Wang L; Du Y; Yao W; Shi X; Niu X; Yuan D; Yao Y; Huang J; Zhang Y; Sun P; Wang H; Ye M; Wang D; Wang Z; Wan B; Lv D; Wei Q; Kang J; Zhang J; Zhang C; Yu G; Ou J; Shi L; Li Z; Liu Z; Liu J; Yang N; Wu L; Wang H; Jin G; Yang L; Wang G; Fang M; Fang Y; Li Y; Wang X; Zhang Y; Ma S; Wang B; Zhang X; Song Y; Lu Y
    Thorac Cancer; 2022 Nov; 13(21):3084-3097. PubMed ID: 36127731
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Cytological and molecular characterization of secretory breast carcinoma.
    Carretero-Barrio I; Santón A; Caniego Casas T; López Miranda E; Reguero-Callejas ME; Pérez-Mies B; Benito A; Palacios J
    Diagn Cytopathol; 2022 Jul; 50(7):E174-E180. PubMed ID: 35156343
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The oncogenic roles of Ntrk fusions and methods of molecular diagnosis.
    Aref-Eshghi E; Lin F; Li MM; Zhong Y
    Cancer Genet; 2021 Nov; 258-259():110-119. PubMed ID: 34710798
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Secretory Carcinoma of the Thyroid in a 49-Year-Old Man Treated with Larotrectinib: Protracted Clinical Course of Disease Despite the High-Grade Histologic Features.
    Saliba M; Mohanty AS; Ho AL; Drilon A; Dogan S
    Head Neck Pathol; 2022 Jun; 16(2):612-620. PubMed ID: 34655408
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Is patient participation in multidisciplinary tumour conferences associated with their information needs? A multicentre prospective observational study.
    Reck S; Diekmann A; Heuser C; Schellenberger B; Ansmann L; Wirtz MA; Ernstmann N
    BMJ Open; 2021 Sep; 11(9):e049199. PubMed ID: 34556513
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Diagnostic challenges and successful organ-preserving therapy in a case of secretory carcinoma of minor salivary glands.
    Bill R; Deschler DG; Pittet MJ; Pai SI; Sadow PM; Park JC
    Cancer Rep (Hoboken); 2022 Mar; 5(3):e1491. PubMed ID: 34231337
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Is patient participation in multidisciplinary tumor conferences associated with their fear of progression?
    Diekmann A; Schellenberger B; Reck S; Heuser C; Geiser F; Wirtz M; Ansmann L; Ernstmann N
    Psychooncology; 2021 Sep; 30(9):1572-1581. PubMed ID: 34004041
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Metastatic leiomyosarcoma of the thyroid: A rare entity.
    Che Jalil NA; Rama Chandran P; Samsudin AHZ; Yahya MM; Wan Abdul Rahman WF
    Malays J Pathol; 2021 Apr; 43(1):69-73. PubMed ID: 33903308
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Factors associated with melanoma-related limb lymphoedema.
    Gjorup CA; Dahlstroem K; Hendel HW; Drzewiecki KT; Klausen TW; Hölmich LR
    Acta Oncol; 2021 Jun; 60(6):779-784. PubMed ID: 33793386
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Nerve growth factor receptor increases the tumor growth and metastatic potential of triple-negative breast cancer cells.
    Wu R; Li K; Yuan M; Luo KQ
    Oncogene; 2021 Mar; 40(12):2165-2181. PubMed ID: 33627781
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Unexpected Pathogenic RET p.V804M Variant Leads to the Clinical diagnosis and Management of Medullary Thyroid Carcinoma.
    Ghazani AA; Breen KM; Dwan M; Barletta JA; Vatnick DR; Stokes SM; Block C; Doherty GM; Cohn AY; Marqusee E; Garber JE; Rana HQ
    Am J Case Rep; 2020 Dec; 21():e927415. PubMed ID: 33361738
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. breast metastasis from medullary carcinoma of thyroid: A case report with literature view.
    Mukhtar R; Hussain M; Mukhtar MA; Ali SM
    J Pak Med Assoc; 2020 Nov; 70(11):2051-2053. PubMed ID: 33341859
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [diagnosis and therapy of tumors with Ntrk gene fusion].
    Stenzinger A; van Tilburg CM; Tabatabai G; Länger F; Graf N; Griesinger F; Heukamp LC; Hummel M; Klingebiel T; Hettmer S; Vokuhl C; Merkelbach-Bruse S; Overkamp F; Reichardt P; Scheer M; Weichert W; Westphalen CB; Bokemeyer C; Ivanyi P; Loges S; Schirmacher P; Wörmann B; Bielack S; Seufferlein TTW
    Pathologe; 2021 Feb; 42(1):103-115. PubMed ID: 33258061
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Novel uses of immunohistochemistry in breast pathology: interpretation and pitfalls.
    Cimino-Mathews A
    Mod Pathol; 2021 Jan; 34(Suppl 1):62-77. PubMed ID: 33110239
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Problematic breast tumors reassessed in light of novel molecular data.
    Pareja F; Weigelt B; Reis-Filho JS
    Mod Pathol; 2021 Jan; 34(Suppl 1):38-47. PubMed ID: 33024304
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Genomic Profiling Aids Classification of Diagnostically Challenging Uterine Mesenchymal Tumors With Myomelanocytic Differentiation.
    Selenica P; Conlon N; Gonzalez C; Frosina D; Jungbluth AA; Beets-Tan RGH; Rao MK; Zhang Y; Benayed R; Ladanyi M; Solit DB; Chiang S; Hyman DM; Hensley ML; Soslow RA; Weigelt B; Murali R
    Am J Surg Pathol; 2021 Jan; 45(1):77-92. PubMed ID: 32889887
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.